ÑÇÐÇÓÎÏ·¹ÙÍø-www.yaxin868.com



    ɽ¶«ÑÇÐÇÓÎÏ·¹ÙÍø»ú´²ÓÐÏÞ¹«Ë¾Ï³´²¹Ù·½ÍøÕ¾½ñÌìÊÇ£º2025-04-04Çл»³ÇÊÐ[È«¹ú]-ÍøÕ¾µØÍ¼
    ÍÆ¼ö²úÆ· :
    ÍÆ¼öÐÂÎÅ
    ¼¼ÊõÎÄÕµ±Ç°Î»ÖÃ:¼¼ÊõÎÄÕÂ>

    ¶à¸ö´«È¾²¡ÏîĿͬʱ¼ì²âµÄø´Ù»¯Ñ§·¢¹âÃâÒß·ÖÎö¶¨ÐÔÕï¶ÏÊÔ¼ÁºÐµÄÖÆ×÷·½·¨

    ʱ¼ä:2025-04-01    ×÷Õß: ¹ÜÀíÔ±

    רÀûÃû³Æ£º¶à¸ö´«È¾²¡ÏîĿͬʱ¼ì²âµÄø´Ù»¯Ñ§·¢¹âÃâÒß·ÖÎö¶¨ÐÔÕï¶ÏÊÔ¼ÁºÐµÄÖÆ×÷·½·¨
    ¼¼ÊõÁìÓò£º
    ±¾·¢Ã÷ÌṩÁËÒ»ÖÖ¶à¸ö´«È¾²¡ÏîĿͬʱ¼ì²âµÄø´Ù»¯Ñ§·¢¹âÃâÒß·ÖÎö¶¨ÐÔÕï¶Ï
    ÊÔ¼ÁºÐ¡£
    ±³¾°¼¼Êõ£º
    °¬×̲¡£¬¼´»ñµÃÐÔÃâÒßȱÏÝ×ÛºÏÖ¢(Acquired Immure Deficiency Syndrome,AIDS)£¬ÊÇÓÉÈËÀàÃâÒßȱÏݲ¡¶¾(human immunodeficiency virus, HIV)ÒýÆðµÄÑÏÖØ¼²²¡¡£AIDS¿Éͨ¹ýÐÔ´«²¥¡¢ÑªÒº´«²¥ºÍĸӤ´«²¥ÈýÖÖ;¾¶¸ÐȾÈËÀà¡£HIV(l+2)¿¹ÌåµÄ¼ì³öÊǰ¬×̲¡Õï¶ÏµÄ±ØÒªÌõ¼þ£¬Ä¿Ç°µÄ°¬×̲¡²¡Ô­Ñ§Õï¶Ï¼¼ÊõÖ÷Òª°üÀ¨HIV²¡¶¾·ÖÀë¡¢HIV²¡¶¾ÔØÁ¿²â¶¨¡¢HIVºËËá²â¶¨£¬ÒÔ¼°²¡¶¾¿¹Ô­¼ì²âºÍ²¡¶¾ÌØÒìÐÔ¿¹Ìå¼ì²âµÈ¡£ÆäÖп¹Ìå¼ì²âÊdz£¹æ¼ì²â·½·¨£¬°üÀ¨ELISA¡¢ CLIA¡¢ PA¡¢ IFAºÍ°ßµãÓ¡¼£ÔÚÄڵļì²â¼¼ÊõÓÃÓÚɸѡʵÑ飬ÃâÒßÓ¡¼£ÊÔÑé(WB)ÓÃÓÚÈ·ÈÏʵÑ飬¿¹Ìå¼ì²âÒÔÍâµÄ·½·¨ÓÃÓÚÌØÊâÇé¿öµÄ¼ì²â¡£ ÷¶¾(Syphilis)ÊÇÓÉ÷¶¾ÂÝÐýÌå(ÓֳƲ԰×ÂÝÐýÌ壬TP)ÒýÆðµÄ³£¼ûÐÔ´«²¥¼²²¡Ö®Ò»¡£ÆäÁÙ´²²¡³ÌÂþ³¤£¬ÁÙ´²±íÏÖ¼«Îª¸´ÔÓ£¬¼¸ºõ¿ÉÇÖ·¸È«Éí¸÷ÖÖ×éÖ¯ºÍÆ÷¹Ù£¬²¢²úÉú¶àÖÖ¶àÑù¸´ÔÓµÄÁÙ´²Ö¢×´ºÍÌåÖ¢£¬¿É·´¸´·¢×÷¡£Ã·¶¾ÊÇÒ»ÖÖÈ«ÉíÐԵļ²²¡£¬ÔçÆÚÖ÷ÒªÇÖ·¸Æ¤·ôճĤ£¬ÍíÆÚÇÖ·¸ÄÚÔàÆ÷¹Ù£¬ÑÏÖØÕß¿ÉÒýÆðÑÏÖØµÄÐÄѪ¹ÜϵͳºÍÉñ¾­ÏµÍ³Ë𺦡£
    ÒÒÐ͸ÎÑ×ÊÇÒ»ÖÖÑÏÖØµÄ³£¼ûµÄ¸ÎÔ༲²¡£¬Ä¿Ç°È«ÇòÈË¿ÚÖУ¬³¬¹ý20ÒÚÈËÒѾ­ÔÚÆäÉúÃüÖеÄij¸öʱÆÚ¸ÐȾ¹ýÒÒÐ͸ÎÑײ¡¶¾(HBV)£¬ÆäÖУ¬´óÔ¼3.5ÒÚÈÔȻΪÂýÐÔ¸ÐȾÕߣ¬³ÉΪ²¡¶¾µÄЯ´øÕß¡£È«ÊÀ½çËÄ·ÖÖ®ÈýµÄÈË¿ÚÉú»îÔÚ¸ÐȾµÄ¸ß·¢Çø¡£Ã¿ÄêHBV¼±ÐÔÁÙ´²²¡Àý³¬¹ý4°ÙÍò£¬Ð¯´øÕßÖдóÔ¼25%£¬Ò²¾ÍÊÇÿÄê100ÍòÈËËÀÓÚÂýÐԻÐÔ¸ÎÑס¢¸ÎÓ²»¯»òÔ­·¢ÐԸΰ©¡£ÎÒ¹úÊÇÊÀ½çÉÏÒҸβ¡¶¾¸ÐȾ×îÑÏÖØµÄ¹ú¼Ò£¬Ô¼ÓÐ1. 2ÒÚÈËΪÒҸβ¡¶¾Ð¯´øÕߣ¬Õ¼ÊÀ½çµÄÈý·ÖÖ®Ò»¡£ÆäÖÐ3000ÍòΪÂýÐÔ¸ÎÑס¢¸ÎÓ²»¯¡¢Ô­·¢ÐԸΰ©£¬Ã¿ÄêÓÐ30ÍòÈËËÀÓÚÂýÐԸβ¡£¬ÆäÖÐÔ¼13ÍòÈËΪԭ·¢ÐԸΰ©»¼Õß¡£ ±ûÐ͸ÎÑ×ÊÇÒ»ÖÖÖ÷Òª¾­ÑªÒº´«²¥¡¢ÓɱûÐ͸ÎÑײ¡¶¾ÒýÆðµÄÑÏÖØ¸ÎÔ༲²¡¡£È«ÊÀ½çĿǰÓÐlÒÚ±ûÐ͸ÎÑײ¡¶¾Ð¯´øÕߣ¬ÖйúÔ¼Õ¼ËÄǧÍòÈË¡£80%µÄ±ûÐ͸ÎÑײ¡¶¾Ð¯´øÕ߻ỼÉÏÂýÐÔ¸ÎÑ×£¬ÆäÖÐÔ¼10-30%µÄ²¡È˽«·¢Õ¹Îª¸ÎÓ²»¯£¬5-10%µÄ¸ÎÓ²»¯»¼Õ߿ɷ¢Õ¹³É¸Î°©¡£
    ÕâЩ´«È¾ÐÔ¼²²¡ÒÑÑÏÖØÍþвÈËÀàµÄ½¡¿µ£¬¶Ô¸¶´«È¾²¡×îÓÐЧµÄ·½·¨¾ÍÊÇÇÐ¶ÏÆä´«²¥Í¾¾¶£¬´«È¾²¡±êÖ¾ÎïµÄ¼ì²â¶Ô¼²²¡µÄÔç·¢ÏÖ£¬ÔçÖÎÁÆ¡¢ÔçÔ¤·ÀÓÈÏÔÖØÒª£¬´«Í³µÄ¼ì²â·½·¨Ö÷ÒªÊǵ¥¸öÏîÄ¿½øÐмì²â£¬²Ù×÷·±Ëö£¬¼ì²âʱ¼ä³¤£¬³É±¾¸ß£¬¶øÇÒÈÝÒ׳öÏÖ²Ù×÷´íÎó¡£
    ÁÙ´²É϶ÔÉÏÊöѪÇå±êÖ¾ÎïµÄ¼ì²â³£³£¶¼Ò»·ÝÑù±¾Ðèͬʱ¼ì²â¼¸¸öÏîÄ¿£¬×î³£¼ûµÄ¼ì²âÏîÄ¿×éºÏÓÐѪԴɸ²éËÄÏî(HIV¿¹Ìå¡¢TP¿¹Ìå¡¢HCV¿¹ÌåºÍHBsAg)£¬¸ÎÎåÏî(HBsAg¡¢HBsAb¡¢ HBeAg¡¢ HBeAbºÍHBcAb)ºÍ´«È¾²¡°ËÏî(HIV¿¹Ìå¡¢TP¿¹Ìå¡¢HCV¿¹Ìå¡¢HBsAg¡¢ HBsAb¡¢HBeAg¡¢ HBeAbºÍHBcAb)¡£ÑªÔ´É¸²éËÄÏî³£ÓÃÓÚ¹©ÑªÕߺͻ¼ÕßÊÖÊõǰµÄ³£¹æ¼ì²â£¬ÒÒ¸ÎÎåÏîÊǹúÄÚÒ»¸ö×î³£¼ûµÄ¼ì²â×éºÏ£¬Ä¿Ç°¹ã·ºÓÃÓÚÁÙ´²¼ì²â£¬´«È¾²¡°ËÏîÒ²³£³£»¼ÕßÊÖÊõǰµÄ¼ì²âÏîÄ¿£¬ÔںܶàÒ½ÁÆ»ú¹¹ÒѾ­³ÉΪһÏîÈëÔº³£¹æ¼ì²â¡£
    3
    Ó봫ͳ¼ì²â·½·¨Ïà±È£¬±¾·¢Ã÷²ÉÓÃÏȽøµÄ΢¿×°å»¯Ñ§·¢¹âÃâÒß·ÖÎö·¨£¬ÔÚÒ»´ÎÊÔÑéÖпÉÒÔͬʱ¶ÔÒ»·ÝÑù±¾½øÐжà¸ö´«È¾²¡ÏîÄ¿µÄ¼ì²â£¬Í¬Ê±µÃµ½¼ì²â½á¹û£»¾ßÓÐÓ봫ͳÊÔ¼ÁºÐÒ»ÑùµÄÁéÃô¶ÈºÍÌØÒìÐÔ£¬µ«²Ù×÷Ò×ÓÃÐÔ´ó´óÌá¸ß£¬¿s¶ÌÁ˲Ù×÷ʱ¼ä¡¢²Ù×÷³ÌÐò£¬¿ÉÁé»îµØ×éºÏ¼¸ÖÖ²»Í¬µÄ¼ì²âÏîÄ¿¡£ÓÐÀûÓÚ´ó¹æÄ£ÍƹãÓ¦Óᣱ¾·¢Ã÷µÄ·´Ó¦Ó봫ͳ»¯Ñ§·¢¹â·¨¼¸ºõÒ»Ñù£¬Ó¦ÓñíÃæÌØÊâ´¦ÀíµÄ±ê×¼²»Í¸Ã÷96¿×΢¿×°å×÷ÎªÔØÌ壬±£Ö¤ÁË·´Ó¦µÄ·½±ãÐÔÓë¿ì½ÝÐÔ£¬¼æÈÝÊг¡ÉÏͨÓõÄËùÓÐÐͺÅÏ´°å»ú»òÈ«/°ë×Ô¶¯°åʽ»¯Ñ§·¢¹âÃâÒß·ÖÎöϵͳ£»½â¾öÁËÆäËü»ùÓÚ²£Æ¬»òĤµÈµÄÉúÎïоƬ·´Ó¦²½ÖèµÄÊÖ¹¤²Ù×÷¹ý¶àÇÒ²Ù×÷¸´ÔÓ¡¢¿ÉÖØ¸´ÐԲ¾ùÒ»ÐÔ²îµÈÎÊÌâ¡£

    ·¢Ã÷ÄÚÈÝ
    ±¾·¢Ã÷µÄÄ¿µÄÊÇÌṩÁ˼ò±ã¡¢¿ì½Ý¡¢×¼È·µÄͬʱ¼ì²â¶à¸ö´«È¾²¡ÏîÄ¿µÄø´Ù»¯Ñ§·¢¹âÃâÒß·ÖÎö¶¨ÐÔÕï¶ÏÊÔ¼ÁºÐ¡£ ±¾·¢Ã÷ÊÇÓÉ96¿×λµÄÖ§³Å¼Ü¼°·ÅÖÃÆäÉϵĿɲðжµÄ²»Í¸Ã÷΢¿×°åÌõ×é³É£¬ÆäÖУ¬Ã¿12¿×Ϊһ¸ö·´Ó¦Ìõ£¬Ã¿¸ö·´Ó¦Ìõ¸ºÔØÏàͬµÄ¿¹Ô­»ò¿¹Ì壬¼ì²âͬһ¸ö´«È¾²¡ÏîÄ¿£¬¿ÉÒÔͬʱ¼ì²â4-8ÖÖ´«È¾²¡ÏîÄ¿¡£ ±¾·¢Ã÷¾«ÐÄÉè¼ÆµÄ96¿×°åø´Ù»¯Ñ§·¢¹âÃâÒß·ÖÎö¶¨ÐÔÕï¶ÏÊÔ¼ÁºÐ£¬¸ß¶ÈÁéÃôºÍÌØÒ죬²Ù×÷¼ò±ã¿ìËÙ£¬¿ÉÔÚÒ»´ÎÊÔÑéÖÐͬʱ¼ì²â4-8ÖÖ´«È¾²¡ÏîÄ¿ÊÇ·ñº¬Óдý²âÎ·ÑÓõÍÁ®¡£Ëü¼ò±ã¿ìËÙ£¬¶à¸ö¼ì²âÏîĿͬʱ¼ÓÑù£¬Í¬Ê±Ï´°å£¬¼õÉÙ¼ÓÑùʱ¼ä£¬±ÜÃâ·´¸´Ê¹ÓÃÑù±¾Ôì³ÉÑù±¾µÄÎÛȾºÍ˳Ðòµßµ¹µÈ²Ù×÷ʧÎ󣬸ù¾Ý¶àÏî¼ì²â½á¹û¶ÔÊܼìÕß½øÐÐ×ÛºÏÅжϣ¬±ãÓÚÑù±¾½á¹ûµÄ´¦ÀíµÈÓŵã¡£±¾·¢Ã÷ÌØ±ðÊʺÏÌå¼ìÖÐÐÄ£¬ÁÙ´²Ò½ÔºÍƹãʹÓã¬ÎªÁÙ´²Õï¶ÏºÍ¿ÆÑй¤×÷ÌṩһÖַdz£ÓÐʵÓüÛÖµµÄ¼ì²âÊֶΡ£


    ͼ1¡¢2±¾·¢Ã÷ʵʩÀý1µÄ½á¹¹Ê¾Òâͼ¡£
    ͼ3±¾·¢Ã÷ʵʩÀý2µÄ½á¹¹Ê¾Òâͼ¡£
    ͼ4±¾·¢Ã÷ʵʩÀý3µÄ½á¹¹Ê¾Òâͼ¡£
    ¾ßÌåʵʩÀý·½Ê½
    ʵʩÀý1ÖÆ±¸ÑªÔ´É¸²é4Ïîͬʱ¼ì²âø´Ù»¯Ñ§·¢¹âÃâÒß·ÖÎö¶¨ÐÔÕï¶ÏÊÔ¼ÁºÐ
    ¡ª¡¢Ã¸±ê¼ÇÎïµÄÖÆ±¸ ÓøÄÁ¼µÄ¹ýµâËáÄÆÑõ»¯·¨±ê¼ÇÈËÀàÃâÒßȱÏݲ¡¶¾1+2ÐÍ¿¹Ô­¡¢Ã·¶¾ÂÝÐýÌ忹ԭ¡¢¿¹ÈËIgG¡¢ÒÒÐ͸ÎÑ×±íÃæ¿¹Ìå¡£ ø±ê¼ÇÎïÏ¡ÊÍÒºÅäÖÆ³ÆÁ¿12. 12gµÄTris£¬9g NaCl£¬ 200mLÐÂÉúţѪÇ壬0. 5mLTween 20ºÍlmL Proclin 300£¬½«ÉÏÊöÊÔ¼Á³ÆÁ¿ºÃ·ÅÈë½à¾»ÈÝÆ÷ÖУ¬µ÷pHÖµ7. 0 7. 5¼ÓË«ÕôË®ÖÁ1L£¬Èܽâ»ìÔÈ¡£ ·Ö±ð²ÉÓÃÆåÅÌʵÑéÑ¡ÔñËÄÖÖø±ê¼ÇÎïµÄ¹¤×÷Ũ¶È¡£Ã¿¸ö²úÆ··Öװһƿ£¬¹²·Ö×°ËÄ
    Æ¿»òËÄÖÖø±ê¼ÇÎï»ìºÏÔÚһƿÖС£ ¶þ¡¢´«È¾²¡ÏîÄ¿¸´ºÏ¶ÔÕÕÆ·µÄÖÆ±¸ ÓÃÈËÀàÃâÒßȱÏݲ¡¶¾¿¹Ìå(Anti-HIV)¡¢Ã·¶¾ÂÝÐýÌ忹Ìå(Anti-TP)¡¢±ûÐ͸ÎÑײ¡¶¾¿¹Ìå(Anti-HCV)¡¢ÒÒÐ͸ÎÑײ¡¶¾±íÃæ¿¹Ô­(HBsAg)ÑôÐÔѪÇå¾­Ãð»îºó£¬ÅäÖÆ³ÉѪԴɸ²é4ÏºÏÑôÐÔ¶ÔÕÕ£¬ÓÃÕý³£ÈËѪÇå»òÐÂÉúţѪÇåÅäÖÆ³É¸´ºÏÒõÐÔ¶ÔÕÕ£¬2mL/Æ¿·Ö×°¡£
    Èý¡¢¹ÌÏà΢¿×°åÌõµÄÖÆ±¸ Èçͼ1Ëùʾ£¬ÔÚ·´Ó¦ÌõA¡¢B°åÌõÉϵÄ΢¿×Öаü±»ÉÏHIV l+2ÐÍ¿¹Ô­£¬CºÍD°åÌõÉϵÄ΢¿×Öаü±»ÉÏ÷¶¾¿¹Ô­(TP15£¬ TP17£¬ TP47µ°°×)£¬ÔÚEºÍF°åÌõÉϵÄ΢¿×Öаü±»ÉϱûÐ͸ÎÑײ¡¶¾¿¹Ô­£¬ÔÚGºÍH°åÌõÉϵÄ΢¿×Öаü±»ÉÏÒÒÐ͸ÎÑײ¡¶¾±íÃæ¿¹Ìå¡£Èç¼ì²âÑù±¾Á¿½ÏÉÙ£¬¿ÉÔÚA DÅÅÒÀ´Î°´ÉÏHIV¡¢ TP¡¢ HCVºÍHBsAgµÄ¹ÌÏà΢¿×°åÌõ£¬Èçͼ2Ëùʾ¡£ËÄÖÖ¼ì²âÏîÄ¿°ü±»°åÌõβÒíÉÏ·Ö±ðÌùÉϱêÓÐ"HIV¡¢ TP¡¢ HCV¡¢ sAg"µÄС±êÇ©¡£
    ËÄ¡¢»¯Ñ§·¢¹âµ×ÎïÒº »¯Ñ§·¢¹âµ×ÎïAÒº£¬°üÀ¨10mM³Ã×ŵ¡¢0. 3mM 4_ôÇ»ùÁª±½¡¢0. 05mM 4-µâ±½ÅðËá¡¢0. 2M pH8. 7ÅðËá-Åðɰ»º³åÒº£¬ÆäpHֵΪ8. 0 10. 0 ; »¯Ñ§·¢¹âµ×ÎïBÒº£¬°üÀ¨3. 5mM¹ýÑõ»¯ëå¡¢0. 1 % Tween20¡¢0. 2M pH7. 2Á×ËáÑλº³åÒº£¬ÆäpHֵΪ7. 0 7. 6¡£
    Îå¡¢20±¶Ï´µÓÒº ³ÆÁ¿24g Tris£¬4gµÄKC1£¬ 160g NaClÓڽྻÈÝÆ÷ÖУ¬¼ÓË«ÕôË®ÖÁ1L£¬Èܽâ»ìÔÈ£¬µ÷ÕûPHÖÁ7. 4¡£ Áù¡¢°ë³ÉÆ·¼°³ÉÆ·×é³É ÉÏÊö²½ÖèËùµÃ²úÆ··Ö×°¼´Îª°ë³ÉÆ·¡£³é³öÈý·Ý¾­¹ýÌØÒìÐÔ¡¢¾«ÃÜÐÔ¡¢ÁéÃô¶È¼°Îȶ¨ÐԼ춨ºÏ¸ñ²ÅÄÜ×é×°³ÉѪԴɸ²éËÄÏîͬʱ¼ì²âø´Ù»¯Ñ§·¢¹âÃâÒß·ÖÎö¶¨ÐÔÕï¶ÏÊÔ¼ÁºÐ¡£×é×°³ÉÊÔ¼ÁºÐºóÐè³é¼ìºÏ¸ñºó²ÅÄܳö³§¡£ ʵʩÀý2ÖÆ±¸ÒÒ¸ÎÎåÏîͬʱ¼ì²âø´Ù»¯Ñ§·¢¹âÃâÒß·ÖÎö¶¨ÐÔÕï¶ÏÊÔ¼ÁºÐ
    ¡ª¡¢Ã¸±ê¼ÇÎïµÄÖÆ±¸ ÓøÄÁ¼µÄ¹ýµâËáÄÆÑõ»¯·¨±ê¼ÇÒÒÐ͸ÎÑײ¡¶¾±íÃæ¿¹Ìå¡¢ÒÒÐ͸ÎÑײ¡¶¾±íÃæ¿¹Ô­¡¢ÒÒÐ͸ÎÑײ¡¶¾e¿¹Ìå¡¢ÒÒÐ͸ÎÑײ¡¶¾ºËÐÄ¿¹Ìå¡£ ø±ê¼ÇÎïÏ¡ÊÍÒºÅäÖÆ³ÆÁ¿12. 12gµÄTris£¬9g NaCl£¬ 200mLÐÂÉúţѪÇ壬0. 5mLTween 20ºÍlmL Proclin 300£¬½«ÉÏÊöÊÔ¼Á³ÆÁ¿ºÃ·ÅÈë½à¾»ÈÝÆ÷ÖУ¬µ÷pHÖµ7. 0 7. 5¼ÓË«ÕôË®ÖÁ1L£¬Èܽâ»ìÔÈ¡£ ·Ö±ð²ÉÓÃÆåÅÌʵÑéÑ¡ÔñËÄÖÖø±ê¼ÇÎïµÄ¹¤×÷Ũ¶È¡£Ã¿¸ö²úÆ··Öװһƿ£¬¹²·Ö×°ËÄÆ¿£¬ÆäÖÐø±êÒÒÐ͸ÎÑײ¡¶¾e¿¹Ìå¿ÉͬʱÓÃÓÚÒÒÐ͸ÎÑײ¡¶¾e¿¹Ô­ºÍe¿¹ÌåµÄ¼ì²â¡£
    ¶þ¡¢´«È¾²¡ÏîÄ¿¸´ºÏУ׼ƷµÄÖÆ±¸ ²ÉÓûùÒò¹¤³ÌHBsAg¡¢»ùÒò¹¤³ÌHBeAgÓÃÐÂÉúţѪÇåÏ¡ÊÍÖÁÒ»¶¨Å¨¶È£¬ÅäÖÆ³ÉÒҸο¹Ô­¸´ºÏÑôÐÔ¶ÔÕÕ£¬Óöà¿Ë¡HBsAb¡¢¶à¿Ë¡HBeAbºÍ¶à¿Ë¡HBcAbÓÃÐÂÉúţѪÇåÏ¡ÊÍÖÁÒ»¶¨Å¨¶È£¬ÅäÖÆ³ÉÒҸο¹Ì帴ºÏ±ê׼Ʒ£¬ÓÃÒÒ¸ÎÎåÏîÈ«ÒõÐÔÕý³£ÈËѪÇå»òÐÂÉúţѪÇåÅäÖÆ³ÉÒҸθ´ºÏÒõÐÔ¶ÔÕÕ£¬·Ö±ð·Ö×°ÒõÑôÐÔ¶ÔÕÕÆ·£¬2mL/Æ¿¡£
    Èý¡¢¹ÌÏà΢¿×°åÌõµÄÖÆ±¸ Èçͼ3Ëùʾ£¬ÔÚ°åÌõAµÄ΢¿×Öаü±»ÒÒÐ͸ÎÑײ¡¶¾±íÃæ¿¹Ì壬ÔÚ°åÌõBÖаü±»ÒÒÐ͸ÎÑײ¡¶¾±íÃæ¿¹Ô­£¬ÔÚ°åÌõC΢¿×Öаü±»ÒÒÐ͸ÎÑײ¡¶¾e¿¹Ì壬ÔÚ°åÌõD΢¿×ÖÐÏȰü±»ÒÒÐ͸ÎÑײ¡¶¾e¿¹Ì壬ÔÙ°ü±»ÊÊÁ¿µÄÒÒÐ͸ÎÑײ¡¶¾e¿¹Ô­£¬ÔÚ°åÌõEµÄ΢¿×Öаü±»ÒÒÐ͸ÎÑײ¡¶¾ºËÐÄ¿¹Ô­£¬°åÌõA-E·Ö±ðÓÃÓÚ¼ì²âHBsAg¡¢HBsAb¡¢HBeAg¡¢HBeAb¡¢HBcAb£¬²¢ÔÚ°åÌõβÒíÉÏ·Ö±ð
    5´òÉϱêÇ©"sAg£¬ sAb£¬ eAg£¬ eAb£¬ cAb£¬£¬¡£
    ËÄ¡¢»¯Ñ§·¢¹âµ×ÎïÒº »¯Ñ§·¢¹âµ×ÎïAÒº£¬°üÀ¨10mM³Ã×ŵ¡¢0. 3mM 4-ôÇ»ùÁª±½¡¢0. 05mM 4-µâ±½ÅðËá¡¢0. 2M pH8. 7ÅðËá-Åðɰ»º³åÒº£¬ÆäpHֵΪ8. 0 10. 0 ; »¯Ñ§·¢¹âµ×ÎïBÒº£¬°üÀ¨3. 5mM¹ýÑõ»¯ëå¡¢0. 1 % Tween20¡¢0. 2M pH7. 2Á×ËáÑλº³åÒº£¬ÆäpHֵΪ7. 0 7. 6¡£
    Îå¡¢20±¶Ï´µÓÒº ³ÆÁ¿24g Tris£¬4gµÄKC1£¬ 160g NaClÓڽྻÈÝÆ÷ÖУ¬¼ÓË«ÕôË®ÖÁ1L£¬Èܽâ»ìÔÈ£¬µ÷ÕûPHÖÁ7. 4¡£ Áù¡¢°ë³ÉÆ·¼°³ÉÆ·×é³É ÉÏÊö²½ÖèËùµÃ²úÆ··Ö×°¼´Îª°ë³ÉÆ·¡£³é³öÈý·Ý¾­¹ýÌØÒìÐÔ¡¢¾«ÃÜÐÔ¡¢ÁéÃô¶È¼°Îȶ¨ÐԼ춨ºÏ¸ñ²ÅÄÜ×é×°³Éͬʱ¼ì²âÒÒ¸ÎÎåÏîø´Ù»¯Ñ§·¢¹âÃâÒß·ÖÎö¶¨ÐÔÕï¶ÏÊÔ¼ÁºÐ¡£×é×°³ÉÊÔ¼ÁºÐºóÐè³é¼ìºÏ¸ñºó²ÅÄܳö³§¡£ ʵʩÀý3ÖÆ±¸´«È¾²¡°ËÏîͬʱ¼ì²âø´Ù»¯Ñ§·¢¹âÃâÒß·ÖÎö¶¨ÐÔÕï¶ÏÊÔ¼ÁºÐ
    ÅäÖÆHIV¿¹Ìå¡¢TP¿¹Ìå¡¢HCV¡¢HBsAg¡¢HBeAg»ìºÏÑôÐÔ¶ÔÕÕ£¬ÓÃÓÚHIV¡¢TP¡¢HCV¡¢HBsAgºÍHBeAg£¬ÅäÖÆHBsAb¡¢ HBeAb¡¢ HBcAbΪÒҸο¹Ìå»ìºÏÑôÐÔ¶ÔÕÕ£¬ÓÃÐÂÉúţѪÇåÅäÖÆÒõÐÔ¶ÔÕÕ¡£·Ö±ð·Ö×°ÒõÑôÐÔ¶ÔÕÕÆ·£¬2mL/Æ¿¡£ ø±ê¼ÇÎïºÍ¹ÌÏà΢¿×°åÌõµÄÖÆ±¸·½·¨Í¬ÊµÊ©Àý1ºÍ2£¬½«°ü±»ºÃµÄ΢¿×°åÌõ°´HIV¡¢TP¡¢HCV¡¢HBsAg¡¢HBsAb¡¢HBeAg¡¢HBeAb¡¢HBcAb˳ÐòÒÀ´Î°²²åÓÚ96¿×Ö§³Å¼ÜA HÅÅÉÏ£¬Èçͼ4¡£ ÊÔ¼ÁºÐÖÐÆäÓà³É·ÖµÄÖÆ±¸·½·¨Í¬ÊµÊ©Àý1ºÍ2¡£
    ʵʩÀý4ͬʱ¼ì²âÊÔ¼ÁºÐµÄʹÓ÷½·¨ µ±Ñù±¾ÐèҪͬʱ¼ì²âHIV¿¹Ìå¡¢TP¿¹Ìå¡¢HCV¿¹ÌåºÍHBsAgʱ£¬Ê¹ÓÃʵʩÀý1ÊÔ¼Á µ±Ñù±¾ÐèҪͬʱ¼ì²âHBsAg¡¢HBsAb¡¢HBeAg¡¢HBeAbºÍHBcAbʱ£¬Ê¹ÓÃʵʩÀý2ÊÔ¼Á µ±Ñù±¾ÐèҪͬʱ¼ì²âHIV¿¹Ìå¡¢TP¿¹Ìå¡¢HCV¿¹Ìå¡¢HBsAg¡¢ HBsAg¡¢ HBsAb¡¢ HBeAg¡¢HBeAbºÍHBcAbʱ£¬Ê¹ÓÃʵʩÀý3ÊÔ¼ÁºÐ¡£ ʵʩÀý1 3ͬʱ¼ì²âø´Ù»¯Ñ§·¢¹âÃâÒß·ÖÎö¶¨ÐÔÕï¶ÏÊÔ¼ÁºÐµÄʹÓ÷½·¨ÈçÏÂ
    È¡³öÊÔ¼ÁºÐÊÒÎÂÆ½ºâ20 30·ÖÖÓ£¬²ð¿ª°ü×°£¬È¡³öËùÓðåÌõ£¬Ê£Óà°åÌõÓÃ×Ô·â´ü
    Ãܷ⣬4t:±£´æ¡£ 1¡¢Ã¿¸ö¼ì²âÏîÄ¿ÉèÒõÐÔ¶ÔÕÕ1 LÑôÐÔ¶ÔÕÕ1¿×£¬È¡Ã¿·ÝÑù±¾·Ö±ð¼ÓÈë°åÌõÏàÓ¦¿×ÄÚ£¬Ã¿¿×50 iU£¬Í¬Ò»·ÝѪ¿ÉÒÔ²»»»¼ÓÑùǹͷÁ¬Ðø¼ÓÑù£¬²»Í¬Ñù±¾¼äÐè¸ü»»Ç¹Í·£¬ÔÙÍùÒõÐÔ¶ÔÕÕ¿×ÄÚ¼ÓÈ븴ºÏÒõÐÔ¶ÔÕÕ50 iU£¬ÑôÐÔ¶ÔÕÕ¿×ÄÚ¼ÓÈëÏàÓ¦µÄ¸´ºÏÑôÐÔ¶ÔÕÕ50 ii 1£¬Õñµ´»ìÔȺó£¬ÖÃÈë37¡£CÎÂÓý30·ÖÖÓ¡£ 2¡¢ÓÃÏ¡ÊͺóµÄÏ´µÓÒº½øÐÐÏ´°å£¬¿ÉÊÖ¹¤Ï´°å£¬Ò²¿ÉÓÃÈ«×Ô¶¯Ï´°å»ú½øÐÐÏ´°å£¬Ã¿¿×¼ÓÈëÏ´µÓÒº50iU£¬½þÅÝÖÁÉÙ10Ã룬ºóÆúÒº»òÎü¸É£¬Èç´Ë·´¸´3 5´Î¡£
    3¡¢Ã¿¿×¼ÓÈëÏàÓ¦µÄø¹¤×÷Òº50 iU£¬ÖÃ37¡£CÎÂÓý30·ÖÖÓ¡£
    4¡¢Èç²½Öè3Ï´°å5´Î
    5¡¢Ã¿¿×¼ÓÈëÒÑ1 : 1»ìºÏµÄ»¯Ñ§·¢¹âµ×ÎïÒº50 lOOul£¬ÖÃÊÒη´Ó¦5·ÖÖÓ¡£
    6¡¢ÓÃ΢¿×°å»¯Ñ§·¢¹â·ÖÎöÒǽøÐжÁÊý£¬¸ù¾ÝCutoffÖµÅжÏÑù±¾ÖÐÊÇ·ñ»¹Óдý²â Îï¡£
    ȨÀûÒªÇó
    Ò»ÖÖ¶à¸ö´«È¾²¡ÏîĿͬʱ¼ì²âµÄø´Ù»¯Ñ§·¢¹âÃâÒß·ÖÎö¶¨ÐÔÕï¶ÏÊÔ¼ÁºÐ£¬ÆäÌØÕ÷ÔÚÓÚ£¬ËùÃèÊöÊÔ¼ÁºÐÊÇÒ»¸ö¿ÉÒÔͬʱ¼ì²â4-8ÖÖ´«È¾²¡ÏîÄ¿µÄø´Ù»¯Ñ§·¢¹âÃâÒß·ÖÎö¶¨ÐÔÕï¶ÏÊÔ¼ÁºÐ¡£
    2. ÈçȨÀûÒªÇó1ËùÊöµÄÊÔ¼ÁºÐ£¬ÆäÌØÕ÷ÔÚÓÚ£¬ËùÊö4-8ÖÖ´«È¾²¡ÏîĿͬʱ¼ì²â°üÀ¨ÑªÔ´É¸²é4Ïîͬʱ¼ì²â£»ÒÒ¸ÎÎåÏîͬʱ¼ì²â£»´«È¾²¡°ËÏîͬʱ¼ì²â¡£
    3. ÈçȨÀûÒªÇó1ËùÊöµÄÊÔ¼ÁºÐ£¬ÆäÌØÕ÷ÔÚÓÚ£¬ËùÊöÊÔ¼ÁºÐ°üÀ¨°ü±»Óв»Í¬¿¹Ô­»ò¿¹Ìå µÄ΢¿×°å¡¢À±¸ù¹ýÑõ»¯Îïø±ê¼ÇµÄÏàÓ¦¿¹Ô­»ò¿¹ÌåµÄ»ìºÏÎï¡¢ÒõÐÔ¶ÔÕÕѪÇå¡¢»ìºÏµÄÑôÐÔ¶Ô ÕÕѪÇ壬Ũ¿sÏ´µÓÒºÒÔ¼°×÷ÓÃÓÚÀ±¸ù¹ýÑõ»¯ÎïøµÄ»¯Ñ§·¢¹âµ×ÎïÒº¡£
    4. ÈçȨÀûÒªÇó2ËùÊöµÄ´«È¾²¡ÏîÄ¿£¬ÆäÌØÕ÷ÔÚÓÚ£¬ËùÊöѪԴɸ²é4ÏîΪÈËÀàÃâÒßȱ Ïݲ¡¶¾(HIV)¿¹Ì塢÷¶¾ÂÝÐýÌå(TP)¿¹Ìå¡¢±ûÐ͸ÎÑײ¡¶¾(HCV)¿¹Ìå¡¢ÒÒÐ͸ÎÑ×±íÃæ¿¹Ô­ (HBsAg)¡£
    5. ÈçȨÀûÒªÇó2ËùÊöµÄ´«È¾²¡ÏîÄ¿£¬ÆäÌØÕ÷ÔÚÓÚ£¬ËùÊöÒÒ¸ÎÎåÏîΪÒÒÐ͸ÎÑ×±íÃæ¿¹Ô­ (HBsAg)¡¢ÒÒÐ͸ÎÑ×±íÃæ¿¹Ìå(HBsAb)¡¢ÒÒÐ͸ÎÑ×e¿¹Ô­(HBeAg)¡¢ÒÒÐ͸ÎÑ×e¿¹Ìå(HBeAb)¡¢ ÒÒÐ͸ÎÑ׺ËÐÄ¿¹Ìå(HBcAb)¡£
    6. ÈçȨÀûÒªÇó2ËùÊöµÄ´«È¾²¡ÏîÄ¿£¬ÆäÌØÕ÷ÔÚÓÚ£¬ËùÊö´«È¾²¡°ËÏîΪÈËÀàÃâÒßȱÏݲ¡ ¶¾¿¹Ì塢÷¶¾ÂÝÐýÌ忹Ìå¡¢±ûÐ͸ÎÑײ¡¶¾¿¹Ìå¡¢ÒÒÐ͸ÎÑ×±íÃæ¿¹Ô­¡¢ÒÒÐ͸ÎÑ×±íÃæ¿¹Ìå¡¢ÒÒÐÍ ¸ÎÑ×e¿¹Ô­¡¢ÒÒÐ͸ÎÑ×e¿¹Ìå¡¢ÒÒÐ͸ÎÑ׺ËÐÄ¿¹Ìå¡£
    7. ÈçȨÀûÒªÇó3ËùÊöµÄÊÔ¼ÁºÐ£¬Æä΢¿×°åÊÇÓÉ96¿×λµÄÖ§³Å¼Ü¼°·ÅÖÃÆäÉϵĿɲðжµÄ ²»Í¸Ã÷΢¿×°åÌõ×é³É£¬ÔÚÿ¸ö¿É²ðжµÄ²»Í¸Ã÷·´Ó¦ÌõÉÏÉèÖ÷´Ó¦¿×£¬ÔÚÿ¸ö·´Ó¦¿×Éϰü±» ÓÐÏàÓ¦µÄ¿¹Ô­»ò¿¹Ì壬ÆäÌØÕ÷ÔÚÓÚÿ12¿×Ϊһ¸ö·´Ó¦Ìõ£¬Ã¿¸ö·´Ó¦Ìõ¸ºÔØÏàͬµÄ¿¹Ô­»ò ¿¹Ì壬¼ì²âͬһ¸ö´«È¾²¡ÏîÄ¿£¬²»Í¬µÄ·´Ó¦Ìõ×éºÏ¿ÉÒÔ4-8ÖÖ´«È¾²¡ÏîĿͬʱ¼ì²â¡£
    8. ÈçȨÀûÒªÇó3ËùÊöµÄÊÔ¼ÁºÐ£¬ÆäÀ±¸ù¹ýÑõ»¯Îïø±ê¼ÇµÄÏàÓ¦¿¹Ô­»ò¿¹ÌåµÄ»ìºÏÎï°ü º¬ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¿¹Ì塢÷¶¾ÂÝÐýÌå(TP)¿¹Ìå¡¢±ûÐ͸ÎÑײ¡¶¾(HCV)¿¹Ìå¡¢ÒÒÐ͸ΠÑ×±íÃæ¿¹Ô­(HBsAg)¡¢ÒÒÐ͸ÎÑ×±íÃæ¿¹Ìå(HBsAb)¡¢ÒÒÐ͸ÎÑ×e¿¹Ô­(HBeAg)¡¢ÒÒÐ͸ÎÑ×e¿¹ Ìå(HBeAb)ºÍÒÒÐ͸ÎÑ׺ËÐÄ¿¹Ìå(HBcAb)£¬ÆäÌØÕ÷ÔÚÓÚÆä»ìºÏÎï·Ö³É2Æ¿£¬HBsAg¡¢HBeAgµÄ ±ê¼ÇÎïºÍHIV¡¢ TP¡¢ HCV¡¢ HBcAbÖÐÈÎÒâ»ìºÏÎï×°³Éһƿ£¬HBsAb¡¢ HBeAbºÍHIV¡¢ TP¡¢ HCV¡¢ HBcAb ÖÐÈÎÒâ»ìºÏÎï×°³ÉÁíһƿ¡£
    9. ÈçȨÀûÒªÇó3ËùÊöµÄÊÔ¼ÁºÐ£¬Æä»ìºÏµÄÑôÐÔ¶ÔÕÕѪÇå°üº¬ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV) ¿¹Ì塢÷¶¾ÂÝÐýÌå(TP)¿¹Ìå¡¢±ûÐ͸ÎÑײ¡¶¾(HCV)¿¹Ìå¡¢ÒÒÐ͸ÎÑ×±íÃæ¿¹Ô­(HBsAg)¡¢ÒÒÐ͸ΠÑ×±íÃæ¿¹Ìå(HBsAb)¡¢ÒÒÐ͸ÎÑ×e¿¹Ô­(HBeAg)¡¢ÒÒÐ͸ÎÑ×e¿¹Ìå(HBeAb)ºÍÒÒÐ͸ÎÑ׺ËÐÄ ¿¹Ìå(HBcAb)£¬ÆäÌØÕ÷ÔÚÓÚÆä»ìºÏÎï·Ö³É2Æ¿£¬HBsAg¡¢HBeAgºÍHIV¡¢TP¡¢HCV¡¢HBcAbÖÐÈÎÒâ »ìºÏÎï×°³Éһƿ£¬HBsAb¡¢ HBeAbºÍHIV¡¢ TP¡¢ HCV¡¢ HBcAbÖÐÈÎÒâ»ìºÏÎï×°³ÉÁíһƿ¡£
    È«ÎÄÕªÒª
    ±¾·¢Ã÷ÌṩÁËÒ»ÖÖ¶à¸ö´«È¾²¡ÏîĿͬʱ¼ì²âµÄø´Ù»¯Ñ§·¢¹âÃâÒß·ÖÎö¶¨ÐÔÕï¶ÏÊÔ¼ÁºÐ¡£±¾·¢Ã÷ÊÇÓɰü±»²»Í¬µÄÏàÓ¦¿¹Ô­»ò¿¹ÌåµÄ΢¿×°åÌõ¡¢»ìºÏµÄÀ±¸ù¹ýÑõ»¯Îïø±ê¼ÇÎï¡¢ÒõÐÔ¶ÔÕÕѪÇå¡¢»ìºÏµÄÑôÐÔ¶ÔÕÕѪÇ塢ŨËõÏ´µÓÒººÍ»¯Ñ§·¢¹âµ×Îï×é³É¡£ÆäÌØÕ÷ÔÚÓÚÿ12¿×Ϊһ¸ö·´Ó¦°åÌõ£¬Ã¿¸ö·´Ó¦°åÌõ¸ºÔØÏàͬµÄ¿¹Ô­»ò¿¹Ì壬¼ì²âͬһ¸ö´«È¾²¡ÏîÄ¿£¬²»Í¬µÄ·´Ó¦Ìõ×éºÏ£¬¿ÉÒÔͬʱ¼ì²â4-8ÖÖ´«È¾²¡ÏîÄ¿¡£±¾·¢Ã÷ÄÜ·½±ã¡¢¿ì½Ýͬʱ¼ì²â¶àÖÖ´«È¾²¡ÏîÄ¿¡£
    Îĵµ±àºÅG01N33/576GK101750493SQ200810240128
    ¹«¿ªÈÕ2010Äê6ÔÂ23ÈÕ ÉêÇëÈÕÆÚ2008Äê12ÔÂ17ÈÕ ÓÅÏÈȨÈÕ2008Äê12ÔÂ17ÈÕ
    ·¢Ã÷ÕßÓÚÉÐÓÀ, ÌÆ±¦¾ü, ӦϣÌÃ, ºú¹úï, Õ²ÏÈ·¢, Ö£½ðÀ´ ÉêÇëÈË:±±¾©¿ÆÃÀ¶«ÑÅÉúÎï¼¼ÊõÓÐÏÞ¹«Ë¾

    • רÀûÃû³Æ£º750kVÏß·´øµç×÷ÒµÓþøÔµ×Ó¼ì²âÆ÷µÄÐÐ×ß×°ÖõÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°Ò»ÖÖÓÃÓÚ³¬¸ßѹÊäµçÏß·´øµç×÷ÒµÓþøÔµ×ÓÐÔÄܲâÊԵļì²âÆ÷£¬¾ßÌåµÄ˵ÊÇÒ»ÖÖ750kvÏß·´øµç×÷ÒµÓþøÔµ×Ó¼ì²âÆ÷µÄÐÐ×ß×°Öᣱ³¾°¼¼Êõ£º¾øÔµ×ÓÊǼܿÕÊäµçÏß·µÄ
    • רÀûÃû³Æ£ºÒ»ÖÖ²âÁ¿Æ«°ÚÁ¿µÄÊýÏÔ²âÁ¿ÒǵÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°©`ÖÖÊýÏÔ²âÁ¿ÒÇ£¬¾ßÌåÊÇÉæ¼°©`ÖÖ²âÁ¿Æ«°ÚÁ¿µÄÊýÏÔ²âÁ¿ÒÇ¡£±³¾°¼¼Êõ£ºÆ«°Ú²âÁ¿ÒÇ£¬Ä¿Ç°Ö÷Òª¼ì²â»úеÉϵÄÖáÀà¡¢ÅÌÀ२¼þµÄ¾¶ÏòÔ²Ìø¶¯£¬Í¨³£Çé¿öÏ£¬¼¼ÊõÈËÔ±½«ÖáÀ२¼þ¹Ì¶¨ÔÚÆ«°Ú²âÁ¿ÒÇ
    • רÀûÃû³Æ£º²ÉÓÃÖÇÄܵç±íµÄ¼Ò¾ÓÓõçÐÅÏ¢¼àÊÓϵͳµÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°Ò»ÖÖ¼Ò¾ÓÓõçÐÅÏ¢¼àÊÓϵͳ£¬ÌرðÉæ¼°Ò»Ö־߱¸ÎÞÏß΢¹¦ÂÊÍø Âç¡¢µÍѹµçÁ¦ÏßÔØ²¨ºÍRS-485×ÜÏßµÈ3ÖÖͨÐÅ·½Ê½µÄ¼Ò¾ÓÓõçÐÅÏ¢¼àÊÓϵͳ¡£±³¾°¼¼Êõ£º´«Í³µÄ¾ÓÃñÓû§ÓõçÐÅÏ¢
    • רÀûÃû³Æ£ºÆû³µgpsÊý×Ö¶¨Î»·ÀµÁ¡¢¼à¿Ø¼°¶¨Î»ÏµÍ³µÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£ºÆû³µGPSÊý×Ö¶¨Î»·ÀµÁ¡¢¼à¿Ø¼°¶¨Î»ÏµÍ³¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°Ò»ÖÖGPS(Global Positioning System È« Çò¶¨Î»ÏµÍ³)£¬¾ßÌåÊÇÒ»ÖÖÓÃÓÚÆû³µÁìÓòÖÐµÄÆû
    • רÀûÃû³Æ£ºÈýά¸´ÔÓµØÖÊÌåÖØ¹¹µÄ¼¼ÊõµÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾·¢Ã÷Éæ¼°Ê¯ÓÍÎï̽¼¼Êõ£¬¾ßÌåÊÇÕë¶Ô¸´ÔÓµØÖÊÌåµÄ¹¹½¨£¬ÊÇÒ»ÖÖÈýά¸´ÔÓµØÖÊÌåÖØ¹¹µÄ¼¼Êõ¡£±³¾°¼¼Êõ£º ÔÚµØÇòÎïÀí¿±Ì½ÖУ¬ÈýάµØÕðµØÖÊÌå¹¹½¨ÇúÃæÖ÷ÒªÊÇ×ÛºÏÀûÓÿ±Ì½½×¶ÎµÄµØÖÊ¡¢²â¾®¡¢Îï̽¡¢Ò°ÍâÑÒʯ
    • רÀûÃû³Æ£ºÓÃÓÚÐγÉÓ¦ÓÃÊÊÌåÉúÎï´«¸ÐÆ÷µÄÎÈ̬»·µÄ·½·¨ºÍ×°ÖõÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾·¢Ã÷Éæ¼°»¯Ñ§ÉúÎï´«¸ÐÆ÷¡£¸ü¾ßÌå¶øÑÔ£¬±¾·¢Ã÷Éæ¼°¹Ì¶¨²¢Áª°å»¯Ñ§ÉúÎï´«¸ÐÆ÷ºÍµçÈÝÆ÷ÕóÁÐÒÔ¼°ÖÆÔìËüÃǵķ½·¨¡£±³¾°¼¼Êõ£ºÑª¹ÜÄÚÆ¤Éú³¤Òò×Ó(VEGF)ÔÚÕý³£Ñª¹Ü·¢ÉúÆÚ¼äÒÔ¼°
    ɽ¶«ÑÇÐÇÓÎÏ·¹ÙÍø»ú´²ÓÐÏÞ¹«Ë¾
    È«¹ú·þÎñÈÈÏߣº13062023238
    µç»°£º13062023238
    µØÖ·£ºëøÖÝÊÐÁúȪ¹¤ÒµÔ°68ºÅ
    ¹Ø¼ü´Ê£ºÏ³´²£¬Êý¿ØÏ³´²£¬ÁúÃÅϳ´²
    ¹«Ë¾¶þάÂë
    Copyright 2010-2024 °æÈ¨ËùÓÐ All rights reserved ³ICP±¸19044495ºÅ-12
    ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿